KALVISTA PHARMACEUTICALS |
USA |
Gesundheit |
US4834971032 / A2DG49 |
4XC1 (Frankfurt) / KALV (NASDAQ) |
FRA:4XC1, ETR:4XC1, 4XC1:GR, NASDAQ:KALV |
- |
https://www.kalvista.com/ |
555.49 Mio. EUR |
- |
-156.29 Mio. EUR |
-2.814 EUR |
5 Mio. EUR |
219.22 Mio. EUR |
- / - |
- / - |
- / 4.41 / - |
- / -150.5% |
- |
- / - |
KALVISTA |
18.07.25 |
|